Skip to content
Subscriber Only

Wall Street Readies for Medical Device M&A Wave After Quiet Year

  • Abbott, J&J, Zimmer among potential buyers, analysts say
  • Edwards, Insulet, Masimo, and Nevro could provide innovation

Photographer: Gerard Julien/AFP/Getty Images

Medical-device makers are charging into 2021 poised for a fresh blast of deal making with soaring share prices and piles of cash at the ready.

The industry, which has surged more than 70% from a March bottom, is “ripe for deals,” according to BNP Paribas Asset Management portfolio manager Christian Fay. Analysts have also been quick to point out Abbott Laboratories, Johnson & Johnson and Zimmer Biomet Holdings Inc. among those most likely to take advantage of low interest rates and strong balance sheets.